non-fungible antibodies
Published 2 years ago • 411 plays • Length 34:09Download video MP4
Download video MP3
Similar videos
-
10:05
why antibody characterization needs an overhaul
-
1:04
how to sequence antibody proteins using mass spec?
-
28:23
antibody protein sequencing: advancing and safeguarding discovery - rapid novor
-
22:53
why is sequence blindness acceptable with antibodies?
-
2:45
who is rapid novor?
-
40:33
leveraging polyclonal antibody sequencing in therapeutics development pipelines
-
36:44
dna vs next gen protein sequencing - a deep dive
-
28:56
routes to nanopore proteomics: from reading peptide barcodes to full-length proteins | jeff nivala
-
6:10
proteon pharmaceuticals’ biotechnology platform is improving animal and human health
-
2:42
from dna to protein - 3d
-
30:46
enriching engineered t-cells with antibody sequencing & modulation
-
27:51
antibody sequencing as a tool to improve reproducibility in the life sciences
-
1:56
remab™ antibody sequencing service report
-
38:23
fully harnessing the power of immunotherapy through protein sequencing
-
2:51
novorcloud - launch
-
1:20
dna sequencing vs. protein sequencing
-
20:47
on-demand webinar: intro to de novo protein sequencing
-
1:01:47
breakthrough bispecific antibody r&d techniques
-
33:33
non-fungible antibodies - monique seymour of rapid novor
-
46:38
navigating intellectual property protection for antibodies
-
1:18:15
rational antibody design and engineering with next generation protein sequencing